Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases
Ricerca Neuromed. Individuata una strada innovativa per la Malattia di Huntington - Istituto Neuromed
IL VIDEO CORONAVIRUS. Ipotesi Neuromed sugli sfingolipidi. Lo studio pubblicato sul British Medical Journal - CasertaCE
Il ricercatore Vittorio Maglione alla prestigiosa Gordon Conference – quotidianomolise.com
Neurology Conferences 2022 | Neuroscience Conferences | Brain Disorders Conference 2022 | Brain Congress 2022 | Neurology Events 2022
Vittorio Maglione | Neurology Conferences 2018 | Neuroscience Conferences | Neurology Congress 2018
Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases
MALATTIE RARE. L'IMPORTANZA DELLA CONOSCENZA | inSalute – Neuromed
POZZILLI – Il ricercatore Neuromed, Vittorio Maglione, al congresso della Gordon Rearch Conference per presentare i suoi lavori. – Paese News cronaca politica sport caserta e provincia
Ricerca: al via a Neuromed e Polo Neurobiotech la settimana della scienza - Tiscali Notizie
Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases
Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases
Frontiers | De novo Synthesis of Sphingolipids Is Defective in Experimental Models of Huntington's Disease | Neuroscience
Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases
Vittorio Maglione (@VittorioMaglio1) / Twitter
vittorio maglione - Country manager Italia - Alliance Laundry System | LinkedIn
Malattie rare, intervista a Vittorio Maglione ricercatore Neuromed - Adnkronos.com
Vittorio Maglione (@VittorioMaglio1) / Twitter
sergio – SPHINGOLIPID CLUB
PDF) Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course
Neurology Conferences 2022 | Neuroscience Conferences | Brain Disorders Conference 2022 | Brain Congress 2022 | Neurology Events 2022
Frontiers | Sphingolipid Metabolism: A New Therapeutic Opportunity for Brain Degenerative Disorders | Neuroscience
